Hai Kerrigan, MD

Kaiser Permanente Medical CenterSan Francisco, California - 94118 (415-833-3480) |
- CLINICAL TRIALS 1
- CONDITIONS0
- INTERVENTIONS1
- SINCE2008

Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
August 2008 - October 2010
Ibalizumab



